Insulin-like growth factor II is involved in the proliferation control of medulloblastoma and its cerebellar precursor cells

American Journal of Pathology

Volumn 166, Issue 4, 2005, Pages 1153-1162

  Hartmann, Wolfgang ^a   Koch, Arend ^a   Brune, Hendrik ^a   Waha, Anke ^a   Schüller, Ulrich ^a   Dani, Indra ^a   Denkhaus, Dorota ^a   Langmann, Wilhelma ^a   Bode, Udo ^a   Wiestler, Otmar D ^a   Schilling, Karl ^a   Pietsch, Torsten ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGENIC AGENT; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SONIC HEDGEHOG PROTEIN;

AKT GENE; ARTICLE; BRAIN TUMOR; CELL LINE; CELL PROLIFERATION; CEREBELLAR GRANULE CELL PRECURSOR; CEREBELLAR PRECURSOR CELL; CEREBELLUM; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; CYCLIN D1 GENE; FETUS; FIBROMA; GENE; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLI1 GENE; GRANULE CELL; GSK 3B GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IGF2 GENE; MEDULLOBLASTOMA; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SHH GENE; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; STEM CELL; TRANSCRIPTION REGULATION; TUMOR BIOPSY;

EID: 20244370527     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)62335-8     Document Type: Article

References (48)

1. Stevens MC, Cameron AH, Muir KR, Parkes SE, Reid H, Whitwell H: Descriptive epidemiology of primary central nervous system tumours in children: a population-based study. Clin Oncol (R Coll Radiol) 1991, 3:323-329
2. Giangasparo F, Bigner SH, Kleihues P, Pietsch T, Trojanowski JQ: Pathology and genetics of tumors of the nervous system. World Health Organization Classification of Tumors. Edited by Kleihues P, Cavenee WK. Lyon, IARC Press, 2000
3. Bühren J, Christoph AH, Buslei R, Albrecht S, Wiestler OD, Pietsch T: Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer. J Neuropathol Exp Neurol 2000, 59:229-240
4. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Unden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE: Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 1996, 85:841-851
5. Raffel C, Jenkins RB, Frederick L, Hebrink D, Alderete B, Fults DW, James CD: Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997, 57:842-845
6. Pietsch T, Scharmann T, Fonatsch C, Schmidt D, Öckler R, Freihoff D, Albrecht S, Wiestler OD, Zeltzer P, Riehm H: Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res 1994, 54:3278-3287
7. Wolter M, Reifenberger J, Sommer C, Ruzicka T, Reifenberger G: Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1997, 57:2581-2585
8. Pietsch T, Waha A, Koch A, Kraus J, Albrecht S, Tonn J, Sörensen N, Berthold F, Henk B, Schmandt N, Wolf HK, von Deimling A, Wainwright B, Chenevix-Trench G, Wiestler OD, Wicking C: Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res 1997, 57:2085-2088
9. Ruiz i Altaba A, Sanchez P, Dahmane N: Gli and Hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002, 2:361-372
10. Goodrich LV, Scott MP: Hedgehog and patched in neural development and disease. Neuron 1998, 21:1243-1257
11. Goodrich LV, Milenkovic L, Higgins KM, Scott MP: Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997, 277:1109-1113
12. Hahn H, Wojnowski L, Zimmer AM, Hall J, Miller G, Zimmer A: Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome. Nat Med 1998, 4:619-622
13. Hahn H, Wojnowski L, Specht K, Kappler R, Calzada-Wack J, Potter D, Zimmer A, Muller U, Samson E, Quintanilla-Martinez L: Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma. J Biol Chem 2000, 275:28341-28344
14. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, Golub TR: Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 2002, 415:436-442
15. Toretsky JA, Helman LJ: Involvement of IGF-II in human cancer. J Endocrinol 1996, 149:367-372
16. van Dijk MA, van Schaik FM, Bootsma HJ, Holthuizen P, Sussenbach JS: Initial characterization of the four promoters of the human insulin-like growth factor II gene. Mol Cell Endocrinol 1991, 81:81-94
17. Vu TH, Hoffman AR: Promoter-specific imprinting of the human insulin-like growth factor-II gene. Nature 1994, 371:714-717
18. Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Wikstrand CJ, Halperin EC, Bigner DD: Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283 Med. J Neuropathol Exp Neurol 1985, 44:592-605
19. Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 1985, 44:472-485
20. He XM, Wikstrand CJ, Friedman HS, Bigner SH, Pleasure S, Trojanowski JQ, Bigner DD: Differentiation characteristics of newly established medulloblastoma cell lines (D384 Med, D425 Med, and D458 Med) and their transplantable xenografts. Lab Invest 1991, 64:833-843
21. Aldosari N, Rasheed BK, McLendon RE, Friedman HS, Bigner DD, Bigner SH: Characterization of chromosome 17 abnormalities in medulloblastomas. Acta Neuropathol (Berl) 2000, 99:345-351
22. Hartmann W, Waha A, Koch A, Albrecht S, Gray SG, Ekström TJ, von Schweinitz D, Pietsch T: Promoter-specific transcription of the IGF2 gene: a novel rapid, non-radioactive and highly sensitive protocol for mRNA analysis. Virchows Arch 2001, 439:803-807
23. Waha A, Watzka M, Koch A, Pietsch T, Przkora R, Peters N, Wiestler OD, von Deimling A: A rapid and sensitive protocol for competitive reverse transcriptase (cRT) PCR analysis of cellular genes. Brain Pathol 1998, 8:13-18
24. Albrecht S, Waha A, Koch A, Kraus JA, Goodyer CG, Pietsch T: Variable imprinting of H19 and IGF2 in fetal cerebellum and medulloblastoma. J Neuropathol Exp Neurol 1996, 55:1270-1276
25. Mertz KD, Weisheit G, Schilling K, Luers GH: Electroporation of primary neural cultures: a simple method for directed gene transfer in vitro. Histochem Cell Biol 2002, 118:501-506
26. Wechsler-Reya RJ, Scott MP: Control of neuronal precursor proliferation in the cerebellum by Sonic hedgehog. Neuron 1999, 22:103-114
27. Kenney AM, Cole MD, Rowitch DH: Nmyc upregulation by Sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 2003, 130:15-28
28. Kenney AM, Rowitch DH: Sonic hedgehog promotes G(1) cyclin expression and sustained cell cycle progression in mammalian neuronal precursors. Mol Cell Biol 2000, 20:9055-9067
29. Oliver TG, Grasfeder LL, Carroll AL, Kaiser C, Gillingham CL, Lin SM, Wickramasinghe R, Scott MP, Wechsler-Reya RJ: Transcriptional profiling of the Sonic hedgehog response: a critical role for N-myc in proliferation of neuronal precursors. Proc Natl Acad Sci USA 2003, 100:7331-7336
30. Kanda S, Mochizuki Y, Suematsu T, Miyata Y, Nomata K, Kanetake H: Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. J Biol Chem 2003, 278:8244-8249
31. Toftgard R: Hedgehog signalling in cancer. Cell Mol Life Sci 2000, 57:1720-1731
32. Tycko B: Genomic imprinting: mechanism and role in human pathology. Am J Pathol 1994, 144:431-443
33. Reifenberger J, Wolter M, Weber RG, Megahed M, Ruzicka T, Lichter P, Reifenberger G: Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998, 58:1798-1803
34. Zurawel RH, Allen C, Chiappa S, Cato W, Biegel J, Cogen P, de Sauvage F, Raffel C: Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma. Genes Chromosom Cancer 2000, 27:44-51
35. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R: Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 1999, 19:3278-3288
36. Wang JY, Del Valle L, Gordon J, Rubini M, Romano G, Croul S, Peruzzi F, Khalili K, Reiss K: Activation of the IGF-IR system contributes to malignant growth of human and mouse medulloblastomas. Oncogene 2001, 20:3857-3868
37. Bondy CA, Werner H, Roberts Jr CT, LeRoith D: Cellular pattern of insulin-like growth factor-I (IGF-I) and type I IGF receptor gene expression in early organogenesis: comparison with IGF-II gene expression. Mol Endocrinol 1990, 4:1386-1398
38. Hetts SW, Rosen KM, Dikkes P, Villa-Komaroff L, Mozell RL: Expression and imprinting of the insulin-like growth factor II gene in neonatal mouse cerebellum. J Neurosci Res 1997, 50:958-966
39. Ohlsson R, Hedborg F, Holmgren L, Walsh C, Ekström TJ: Overlapping patterns of IGF2 and H19 expression during human development: biallelic IGF2 expression correlates with a lack of H19 expression. Development 1994, 120:361-368
40. de Pablo F, de la Rosa EJ: The developing CNS: a scenario for the action of proinsulin, insulin and insulin-like growth factors. Trends Neurosci 1995, 18:143-150
41. Ruiz i Altaba A: Gli proteins and Hedgehog signaling: development and cancer. Trends Genet 1999, 15:418-425
42. Nilsson M, Unden AB, Krause D, Malmqwist U, Raza K, Zaphiropoulos PG, Toftgard R: Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci USA 2000, 97:3438-3443
43. Sherr CJ: Cancer cell cycles. Science 1996, 274:1672-1677
44. Del Valle L, Enam S, Lassak A, Wang JY, Croul S, Khalili K, Reiss K: Insulin-like growth factor I receptor activity in human medulloblastomas. Clin Cancer Res 2002, 8:1822-1830
45. Chin LS, Yung WK, Raffel C: Two primitive neuroectodermal tumor cell lines require an activated insulin-like growth factor I receptor for growth in vitro. Neurosurgery 1996, 39:1183-1190
46. Parti R, Reddy CD, Geoerger B, Grotzer MA, Raghunath M, Sutton LN, Phillips PC: Autocrine secreted insulin-like growth factor-I stimulates MAP kinase-dependent mitogenic effects in human primitive neuroectodermal tumor/medulloblastoma. Int J Oncol 2000, 16:577-584
47. Diehl JA, Cheng M, Roussel MF, Sherr CJ: Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998, 12:3499-3511
48. Kenney AM, Widlund HR, Rowitch DH: Hedgehog and PI-3 kinase signaling converge on Nmyd to promote cell cycle progression in cerebellar neuronal precursors. Development 2004, 131:217-228